[Severe epistaxis secondary to ticlopidine. Report of 3 cases].
Ticlopidine (Ticlid@) is a platelet aggregation inhibitor that can produce bleeding or severe hemorrhage as a side-effect. The cases of three patients on previous treatment with that drug that required admission in our hospital because of recurrent epistaxis are reported. We have analysed their personal antecedents, complementary explorations, type of nasal packing used, clinical evolution and stay.
Pino Rivero
V
V
Complejo Hospitalario Infanta Cristina, Badajoz. vicentepinorivero@terra.com
Marcos García
M
M
Trinidad Ruíz
G
G
Keituqwa Yáñez
T
T
Pardo Romero
G
G
González Palomino
A
A
Blasco Huelva
A
A
D000368:Aged; D000369:Aged, 80 and over; D004844:Epistaxis / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D013630:Tampons, Surgical; D013988:Ticlopidine / Q000008:administration & dosage / Q000009:adverse effects*; D016896:Treatment Outcome
D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine
Epístaxis intensa secundaria a ticlopidina. Presentación de 3 casos.